Miriam O'Sullivan - 12 Feb 2025 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role
SVP, Chief HR Officer
Signature
/s/ Susan Thompson, Attorney-in-Fact
Issuer symbol
BSX
Transactions as of
12 Feb 2025
Net transactions value
-$38,183
Form type
4
Filing time
14 Feb 2025, 17:30:02 UTC
Previous filing
06 Jan 2025
Next filing
18 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BSX Common Stock Options Exercise $0 +961 +8% $0.000000 12,917 12 Feb 2025 Direct F1
transaction BSX Common Stock Tax liability $35,750 -338 -2.6% $105.77 12,579 12 Feb 2025 Direct
transaction BSX Common Stock Options Exercise $0 +65 +4.3% $0.000000 1,567 12 Feb 2025 By Spouse F1, F2
transaction BSX Common Stock Tax liability $2,433 -23 -1.5% $105.77 1,544 12 Feb 2025 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BSX Restricted Stock Units Options Exercise $0 -961 -25% $0.000000 2,885 12 Feb 2025 Common Stock 961 Direct F1, F3
transaction BSX Restricted Stock Units Options Exercise $0 -65 -25% $0.000000 196 12 Feb 2025 Common Stock 65 By Spouse F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2 Includes shares acquired under the Boston Scientific Employee Stock Purchase Plan based upon the most current data available.
F3 Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 12, 2025, the first anniversary of the date of grant.